MARKET

PFE

PFE

Pfizer
NYSE
26.65
-0.21
-0.78%
After Hours: 26.62 -0.03 -0.11% 19:59 02/20 EST
OPEN
26.71
PREV CLOSE
26.86
HIGH
26.78
LOW
26.36
VOLUME
44.79M
TURNOVER
--
52 WEEK HIGH
27.94
52 WEEK LOW
19.50
MARKET CAP
151.52B
P/E (TTM)
19.59
1D
5D
1M
3M
1Y
5Y
1D
Notable healthcare headlines for the week: J&J, Masimo and Bayer in focus
Seeking Alpha · 2h ago
Merck: Why Investors Should Remain Bullish Despite Patent Risks
Seeking Alpha · 3h ago
Massive News: Pfizer's 6% Dividend Could Be Safer Than You Think
The Motley Fool · 1d ago
Pfizer: A Risky 6.3% Yield For Income-Oriented Investors
Seeking Alpha · 1d ago
Is Pfizer Stock an Underrated Healthcare Investment Play?
The Motley Fool · 1d ago
Pharmaceutical tariffs still in play despite Supreme Court ruling
Seeking Alpha · 1d ago
This Pfizer Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Friday
Benzinga · 1d ago
Moderna Faces Lawsuit From BioNTech Over Next-Generation COVID-19 Shot
Benzinga · 2d ago
More
About PFE
Pfizer Inc. is a research-based, global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment includes the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its oncology products include Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak and Talzenna. Its primary care products include Eliquis, Nurtec ODT/Vydura, Zavzpret, the Prevnar family, Comirnaty, Abrysvo, FSME/IMMUN-TicoVac, Nimenrix, Trumenba, and Paxlovid. Its specialty care products include Xeljanz, Enbrel (outside the United States and Canada), Inflectra, Abrilada, Cibinqo, Litfulo, Eucrisa, Velsipity, the Vyndaqel family, Genotropin, and others. Its PF-08653944 is an ultra-long-acting fully biased GLP-1 receptor agonist.

Webull offers Pfizer Inc stock information, including NYSE: PFE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PFE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PFE stock methods without spending real money on the virtual paper trading platform.